Dr. Camille Rochmann, Director of Value & Access at Cilcare.

Cilcare is a French-American biopharmaceutical company dedicated to making hearing a priority in global health through the development of innovative therapies, next-generation diagnostics, and AI-driven solutions for hearing disorders.

Dr. Rochmann earned her Doctor of Pharmacy degree and a Specialized Master's degree in Pharmacoeconomics and Market Access from Paris-Saclay University. She has over 10 years of experience in health economics and outcomes research, including a successful career at Sanofi, where she worked on market access and evidence generation strategies for products in immunology and rare diseases.

Today, she brings this expertise to the field of hearing health, where she is leading efforts to ensure that innovation translates into meaningful value for patients, healthcare systems, and society.